The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (unres) Regulatory News (SPSY)

Share Price Information for Spectra (unres) (SPSY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 245.00
Bid: 240.00
Ask: 250.00
Change: 0.00 (0.00%)
Spread: 10.00 (4.167%)
Open: 245.00
High: 245.00
Low: 245.00
Prev. Close: 245.00
SPSY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second G8 Central Bank Test Program

13 Jan 2014 07:00

RNS Number : 4338X
Spectra Systems Corporation
13 January 2014
 



Spectra Systems Corporation ("Spectra Systems" or the "Company")

 

Second G 8 central bank test program for supercritical fluid cleaning of banknotes

 

The Board is delighted to announce that Spectra Systems has agreed to enter into a testing program scheduled to begin in April of this year, with a second G 8 central bank to evaluate its supercritical CO2 ("SCCO2") technology involving the use of supercritical fluids to clean heavily soiled banknotes, thereby allowing them to be returned to circulation and effectively increasing their life. This follows the ongoing trial with the first G8 central bank announced on 25 November 2013.

With banknote replacement costs approaching $10 billion annually, and most banknotes being replaced due to soiling, data from these central bank testing programs will be invaluable to the Company for determining the potential of this technology for creating a sizable revenue steam if adopted by major central banks. Spectra Systems will provide data to the industry from these trials at the Banknote 2014 conference in Washington DC commencing on 7 April 2014.

Spectra Systems also announces that its seminal work on the cleaning of soiled banknotes using SCCO2 has been published in the prestigious peer reviewed journal of the American Chemical Society, Industrial and Chemical Engineering Research. The paper, entitled "Supercritical Fluid Cleaning of Banknotes", is authored by Nabil M. Lawandy and Andrei Y. Smuk, Spectra's CEO and Director of Research and Development, respectively. The American Chemical Society has chosen to highlight this work in a featured press release http://www.acs.org/content/acs/en/pressroom.html) which has received broad coverage, including the Los Angeles Times (http://touch.latimes.com/#section/-1/article/p2p-78822882/) and other international news bureaus (see News section on the Company website: http://www.spectra-science.com/company-news.html)

 

Nabil Lawandy, Spectra System's CEO, stated:

"Spectra Systems is founded on cutting edge technology and the publication of our work in a leading scientific journal provides third party validation for its breakthrough technical results. The addition of a second G 8 central bank to the testing program will provide more data to help us formulate a compelling business proposition to the industry"

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

WH Ireland Limited

Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBMMFTMBIBBBI
Date   Source Headline
19th Mar 20187:00 amRNSPreliminary Results
1st Feb 20184:40 pmRNSSecond Price Monitoring Extn
1st Feb 20184:35 pmRNSPrice Monitoring Extension
1st Feb 20187:00 amRNSTrading Update
15th Jan 20187:00 amRNSLicensing Agreement and Supply Agreement
11th Dec 20177:00 amRNSAnnual General Meeting Postponed
10th Nov 20174:32 pmRNSHolding(s) in Company
23rd Oct 20173:44 pmRNSExercise of Options
16th Oct 20177:00 amRNSTrading Update
5th Oct 20177:00 amRNSNew Opportunity in Consumer Products
14th Sep 20175:34 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSInterim Results
21st Aug 20177:00 amRNSTrading Update and Interim Results Date
18th Jul 20177:00 amRNSRegulatory Approval for TruBrand Materials, China
7th Jul 20177:08 amRNSHolding(s) in Company
26th Jun 20177:00 amRNSIssuance of Patents
22nd Jun 20172:18 pmRNSPosting of Annual Report and Accounts
18th May 20173:47 pmRNSExercise of Options
5th May 20172:01 pmRNSExercise of Options
13th Apr 201711:26 amRNSExercise of Options
30th Mar 20177:00 amRNSPreliminary Results
17th Mar 20177:00 amRNSAppointment of Chief Financial Officer
23rd Jan 20177:00 amRNSAppointment of Chief Financial Officer
11th Jan 20177:00 amRNSIssuance of Patents
4th Jan 20177:00 amRNSTrading Update
5th Dec 20167:00 amRNSResignation of Chief Financial Officer
1st Dec 20167:00 amRNSAnnual General Meeting Postponed
3rd Oct 20167:00 amRNSNew Five Year Contract with G7 Central Bank
21st Sep 20165:06 pmRNSHolding(s) in Company
19th Sep 20167:00 amRNSInterim Results for 6 Months ended 30 June 2016
7th Sep 20167:00 amRNSInterim Results Pre-announcement
24th Jun 20167:00 amRNSPosting of Annual Report and Accounts
31st May 20167:00 amRNSGrant of share options
25th May 20165:12 pmRNSHolding(s) in Company
5th May 20167:00 amRNSFirst TruBrand customer
18th Apr 20169:41 amRNSHolding(s) in Company
18th Apr 20167:00 amRNSPreliminary Results
16th Feb 20167:00 amRNSExpected grant of share options
8th Feb 20167:00 amRNSTrading update and expected grant of share options
29th Jan 20167:00 amRNS$3m Acquisition of Key Specialty Phosphour Assets
27th Jan 20164:01 pmRNSHolding(s) in Company
17th Dec 20154:34 pmRNSRemoval of Restrictions from Common Stock
30th Nov 20157:00 amRNSHolding(s) in Company
17th Nov 20157:00 amRNSAGM Postponement
4th Nov 20154:28 pmRNSHolding(s) in Company
4th Nov 20151:57 pmRNSRemoval of Restrictions from Common Stock
16th Oct 20159:53 amRNSRemoval of Restrictions from Common Stock
2nd Oct 20153:17 pmRNSNotice of AGM
10th Sep 20152:30 pmRNSHolding(s) in Company
1st Sep 20154:41 pmRNSSettlement of Common Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.